« Previous
Next »
Titles
- PEPFAR: 20 years of progress, partnership, and impact1
- Part D plans generally include drugs commonly used by dual-eligible enrollees: 20231
- Payment integrity: additional coordination is needed for assessing risks in the improper payment estimation process for advance premium tax credits : report to congressional requesters1
- Pennsylvania could better ensure that nursing homes comply with federal requirements for life safety, emergency preparedness, and infection control1
- Pennsylvania implemented our prior audit recommendations for critical incidents involving Medicaid enrollees with developmental disabilities but should continue to take action to reduce unreported incidents1
- Peripheral percutaneous transluminal angioplasty (PTA) and specialty catheters: premarket notification (510(k)) submissions : guidance for industry and Food and Drug Administration staff1
- Policy for testing of alcohol (ethanol) and isopropyl alcohol for methanol: guidance for industry1
- Presenting quantitative efficacy and risk information in direct-to-consumer (DTC) promotional labeling and advertisements: guidance for industry1
- Private health coverage: information on farm bureau health plans, health care sharing ministries, and fixed indemnity plans : report to congressional requesters1
- Private health insurance: Roll out of independent dispute resolution process for out-of-network claims has been challenging : report to congressional committees1
- Progress and ongoing challenges to electronic public health reporting among non-federal acute care hospitals1
- Project update: Child Welfare and Health Infrastructure for Linking and Data Analysis of Resources, Effectiveness, and Needs (CHILDREN) initiative1
- Projected impacts for Asian Medicare enrollees1
- Projected impacts for Black Medicare enrollees1
- Projected impacts for Latino Medicare enrollees1
- Public health preparedness: Building and maintaining infrastructure beyond the COVID-19 pandemic : report to congressional committees1
- Public health preparedness: Critical need to address deficiencies in HHS’s leadership and coordination of emergencies : testimony before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives1
- Public health preparedness: HHS could improve oversight of research involving enhanced potential pandemic pathogens : report to congressional committees1
- Public health preparedness: HHS should plan for medical countermeasure development and manufacturing risks : report to Congressional committees1
- Public health: Leading practices could help guide HHS reform efforts to address risk and improve preparedness : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives1